Test Code PNEFC Neuroimmunology Antibody Follow-up, Spinal Fluid
Reporting Name
Neuroimmunology Ab Follow-up, CSFUseful For
Monitoring patients who have previously tested positive for 1 or more antibodies within the past 5 years in a Mayo Clinic Neuroimmunology Laboratory spinal fluid evaluation
Reflex Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
AMPCC | AMPA-R Ab CBA, CSF | No | No |
AMPHC | Amphiphysin Ab, CSF | No | No |
AGN1C | Anti-Glial Nuclear Ab, Type 1 | No | No |
ANN1C | Anti-Neuronal Nuclear Ab, Type 1 | No | No |
ANN2C | Anti-Neuronal Nuclear Ab, Type 2 | No | No |
ANN3C | Anti-Neuronal Nuclear Ab, Type 3 | No | No |
CS2CC | CASPR2-IgG CBA, CSF | No | No |
CRMWC | CRMP-5-IgG Western Blot, CSF | No | No |
CRMC | CRMP-5-IgG, CSF | No | No |
GABCC | GABA-B-R Ab CBA, CSF | No | No |
LG1CC | LGI1-IgG CBA, CSF | No | No |
NMDCC | NMDA-R Ab CBA, CSF | No | No |
PCTRC | Purkinje Cell Cytoplasmc Ab Type Tr | No | No |
PCA1C | Purkinje Cell Cytoplasmic Ab Type 1 | No | No |
PCA2C | Purkinje Cell Cytoplasmic Ab Type 2 | No | No |
DPPCC | DPPX Ab CBA, CSF | No | No |
DPPIC | DPPX Ab IFA, CSF | No | No |
GL1CC | mGluR1 Ab CBA, CSF | No | No |
GL1IC | mGluR1 Ab IFA, CSF | No | No |
AGNBC | AGNA-1 Immunoblot, CSF | No | No |
AINCC | Alpha Internexin CBA, CSF | No | No |
AMIBC | Amphiphysin Immunoblot, CSF | No | No |
AN1BC | ANNA-1 Immunoblot, CSF | No | No |
AN2BC | ANNA-2 Immunoblot, CSF | No | No |
APBCC | AP3B2 CBA, CSF | No | No |
APBIC | AP3B2 IFA, CSF | No | No |
GFACC | GFAP CBA, CSF | No | No |
GFAIC | GFAP IFA, CSF | No | No |
GRFCC | GRAF1 CBA, CSF | No | No |
GRFIC | GRAF1 IFA, CSF | No | No |
IG5CC | IgLON5 CBA, CSF | No | No |
IG5IC | IgLON5 IFA, CSF | No | No |
ITPCC | ITPR1 CBA, CSF | No | No |
ITPIC | ITPR1 IFA, CSF | No | No |
NCDIC | Neurochondrin IFA, CSF | No | No |
NCDCC | Neurochondrin CBA, CSF | No | No |
NFHCC | NIF Heavy Chain CBA, CSF | No | No |
NIFIC | NIF IFA, CSF | No | No |
NFLCC | NIF Light Chain CBA, CSF | No | No |
PC1BC | PCA-1 Immunoblot, CSF | No | No |
PCTBC | PCA-Tr Immunoblot, CSF | No | No |
SP5CC | Septin-5 CBA, CSF | No | No |
SP5IC | Septin-5 IFA, CSF | No | No |
SP7CC | Septin-7 CBA, CSF | No | No |
SP7IC | Septin-7 IFA, CSF | No | No |
PDEIC | PDE10A Ab IFA, CSF | No | No |
T46CC | TRIM46 Ab CBA, CSF | No | No |
T46IC | TRIM46 Ab IFA, CSF | No | No |
Method Name
AMPHC, AGN1C, ANN1C, ANN2C, ANN3C, PCTRC, PCA1C, PCA2C, DPPTC, GL1IC, GFAIC, IG5IC, ITPIC, GRFIC, NIFIC, APBIC, SP5IC, SP7IC, CRMC, NCDIC, DPPIC, PDEIC, T46IC: Indirect Immunofluorescence Assay (IFA)
AMPCC, CS2CC, GABCC, LG1CC, NMDCC, DPPCC, GL1CC, GFACC, IG5CC, ITPCC, GRFCC, NFLCC, NFHCC, AINCC, APBCC, NCDCC, SP5CC, SP7CC, T46CC: Cell Binding Assay (CBA)
CRMWC: Western Blot (WB)
AN1BC, AN2BC, AMIBC, PC1BC, PCTBC, AGNBC: Immunoblot (IB)
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
CSFOrdering Guidance
This test is only appropriate for follow-up in patients who have previously tested positive in a spinal fluid test. If patients have not previously been positive in a spinal fluid test, order one of the following:
-DMC2 / Dementia, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
-ENC2 / Encephalopathy, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
-EPC2 / Epilepsy, Autoimmune/Paraneoplastic Evaluation, Serum
-MAC1 / Myelopathy, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
-MDC2 / Movement Disorder, Autoimmune/Paraneoplastic Evaluation, Spinal Fluid
-PCDEC / Pediatric Autoimmune Encephalopathy/CNS Disorder Evaluation, Spinal Fluid
-SPPC / Stiff-Person Spectrum Disorders/PERM Evaluation, Spinal Fluid
This test should not be requested in patients who have recently received radioisotopes, therapeutically or diagnostically, because of potential assay interference. The specific waiting period before specimen collection will depend on the isotope administered, the dose given, and the clearance rate in the individual patient. Specimens will be screened for radioactivity prior to analysis. Radioactive specimens received in the laboratory will be held 1 week and assayed if sufficiently decayed or canceled if radioactivity remains.
Specimen Required
Container/Tube: Sterile vial
Preferred: Vial number 1
Acceptable: Any vial
Specimen Volume: 4 mL
Specimen Minimum Volume
2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
CSF | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | Reject |
Reference Values
Test ID |
Reporting Name |
Methodology* |
Reference Value |
AGNBC |
AGNA-1 Immunoblot, CSF |
IB |
Negative |
AINCC |
Alpha Internexin CBA, CSF |
CBA |
Negative |
AMPCC |
AMPA-R Ab CBA, CSF |
CBA |
Negative |
AMPHC |
Amphiphysin Ab, CSF |
IFA |
Negative |
AMIBC |
Amphiphysin Immunoblot, CSF |
IB |
Negative |
AN1BC |
ANNA-1 Immunoblot, CSF |
IB |
Negative |
AN2BC |
ANNA-2 Immunoblot, CSF |
IB |
Negative |
AGN1C |
Anti-Glial Nuclear Ab Type 1 |
IFA |
Negative |
ANN1C |
Anti-Neuronal Nuclear Ab, Type 1 |
IFA |
Negative |
ANN2C |
Anti-Neuronal Nuclear Ab, Type 2 |
IFA |
Negative |
ANN3C |
Anti-Neuronal Nuclear Ab, Type 3 |
IFA |
Negative |
APBCC |
AP3B2 CBA, CSF |
CBA |
Negative |
APBIC |
AP3B2 IFA, CSF |
IFA |
Negative |
CS2CC |
CASPR2-IgG CBA, CSF |
CBA |
Negative |
CRMWC |
CRMP-5-IgG Western Blot, CSF |
WB |
Negative |
CRMC |
CRMP-5-IgG, CSF |
IFA |
Negative |
DPPCC |
DPPX Ab CBA, CSF |
CBA |
Negative |
DPPIC |
DPPX Ab IFA, CSF |
IFA |
Negative |
GABCC |
GABA-B-R Ab CBA, CSF |
CBA |
Negative |
GFACC |
GFAP CBA, CSF |
CBA |
Negative |
GFAIC |
GFAP IFA, CSF |
IFA |
Negative |
GRFCC |
GRAF1 CBA, CSF |
CBA |
Negative |
GRFIC |
GRAF1 IFA, CSF |
IFA |
Negative |
IG5CC |
IgLON5 CBA, CSF |
CBA |
Negative |
IG5IC |
IgLON5 IFA, CSF |
IFA |
Negative |
ITPCC |
ITPR1 CBA, CSF |
CBA |
Negative |
ITPIC |
ITPR1 IFA, CSF |
IFA |
Negative |
LG1CC |
LGI1-IgG CBA, CSF |
CBA |
Negative |
GL1CC |
mGluR1 Ab CBA, CSF |
CBA |
Negative |
GL1IC |
mGluR1 Ab IFA, CSF |
IFA |
Negative |
NCDCC |
Neurochondrin CBA, CSF |
CBA |
Negative |
NCDIC |
Neurochondrin IFA, CSF |
IFA |
Negative |
NFHCC |
NIF Heavy Chain CBA, CSF |
CBA |
Negative |
NIFIC |
NIF IFA, CSF |
IFA |
Negative |
NFLCC |
NIF Light Chain CBA, CSF |
CBA |
Negative |
NMDCC |
NMDA-R Ab CBA, CSF |
CBA |
Negative |
PC1BC |
PCA-1 Immunoblot, CSF |
IB |
Negative |
PCTBC |
PCA-Tr Immunoblot, CSF |
IB |
Negative |
PCTRC |
Purkinje Cell Cytoplasmc Ab Type Tr |
IFA |
Negative |
PCA1C |
Purkinje Cell Cytoplasmic Ab Type 1 |
IFA |
Negative |
PCA2C |
Purkinje Cell Cytoplasmic Ab Type 2 |
IFA |
Negative |
SP5CC |
Septin-5 CBA, CSF |
CBA |
Negative |
SP5IC |
Septin-5 IFA, CSF |
IFA |
Negative |
SP7CC |
Septin-7 CBA, CSF |
CBA |
Negative |
SP7IC |
Septin-7 IFA, CSF |
IFA |
Negative |
PDEIC |
PDE10A Ab IFA, CSF |
IFA |
Negative |
T46CC |
TRIM46 Ab CBA, CSF |
CBA |
Negative |
T46IC |
TRIM46 Ab IFA, CSF |
IFA |
Negative |
*Methodology abbreviations:
CBA: Cell-binding assay
IB: Immunoblot
IFA: Immunofluorescence assay
WB: Western blot (WB)
Day(s) Performed
Varies
CPT Code Information
84182 AGNBC (if appropriate)
86255 AINCC (if appropriate)
86255 AMPCC (if appropriate)
86255 AMPHC (if appropriate)
84182 AMIBC (if appropriate)
84182 AN1BC (if appropriate)
84182 AN2BC (if appropriate)
86255 AGN1C (if appropriate)
86255 ANN1C (if appropriate)
86255 ANN2C (if appropriate)
86255 ANN3C (if appropriate)
86255 APBCC (if appropriate)
86255 APBIC (if appropriate)
86255 CS2CC (if appropriate)
84182 CRMWC (if appropriate)
86255 CRMC (if appropriate)
86255 DPPCC (if appropriate)
86255 DPPIC (if appropriate)
86255 GABCC (if appropriate)
86255 GFACC (if appropriate)
86255 GFAIC (if appropriate)
86255 GRFCC (if appropriate)
86255 GRFIC (if appropriate)
86255 IG5CC (if appropriate)
86255 IG5IC (if appropriate)
86255 ITPCC (if appropriate)
86255 ITPIC (if appropriate)
86255 LG1CC (if appropriate)
86255 GL1CC (if appropriate)
86255 GL1IC (if appropriate)
86255 NCDCC (if appropriate)
86255 NCDIC (if appropriate)
86255 NFHCC (if appropriate)
86255 NIFIC (if appropriate)
86255 NFLCC (if appropriate)
86255 NMDCC (if appropriate)
84182 PC1BC (if appropriate)
84182 PCTBC (if appropriate)
86255 PCTRC (if appropriate)
86255 PCA1C (if appropriate)
86255 PCA2C (if appropriate)
86255 PDEIC (if appropriate)
86255 SP5CC (if appropriate)
86255 SP5IC (if appropriate)
86255 SP7CC (if appropriate)
86255 SP7IC (if appropriate)
86255 T46CC (if appropriate)
86255 T46IC (if appropriate)
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
PNEFC | Neuroimmunology Ab Follow-up, CSF | 80615-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
84299 | Neuroimmunology Ab Follow-up, CSF | 80615-8 |
Report Available
VariesNY State Approved
YesTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Forms
If not ordering electronically, complete, print, and send a Neurology Specialty Testing Client Test Request (T732) with the specimen.